Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 30026 - 30050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Deferoxamine	Approved Investigational	LEP	3952	upregulated	Deferoxamine results in increased expression of LEP mRNA	7q32.1	A22065
Deferoxamine	Approved Investigational	LIPE	3991	downregulated	Deferoxamine results in decreased expression of LIPE mRNA	19q13.2	A22065
Deferoxamine	Approved Investigational	LOX	4015	upregulated	[Deferoxamine results in decreased abundance of Iron] which results in increased expression of LOX mRNA	5q23.1	A22066
Deferoxamine	Approved Investigational	MT2A	4502	upregulated	[Deferoxamine results in decreased abundance of Iron] which results in increased expression of MT2A mRNA	16q13	A22066
Deferoxamine	Approved Investigational	MYC	4609	downregulated	[Deferoxamine results in decreased abundance of Iron] which results in decreased expression of MYC mRNA	8q24.21	A22066
Deferoxamine	Approved Investigational	NDRG1	10397	upregulated	Deferoxamine results in increased expression of NDRG1 mRNA	8q24.22	A22070
Deferoxamine	Approved Investigational	NQO1	1728	downregulated	Deferoxamine results in decreased expression of NQO1 mRNA	16q22.1	A22053
Deferoxamine	Approved Investigational	PDK1	5163	upregulated	Deferoxamine results in increased expression of PDK1 mRNA	2q31.1	A22071
Deferoxamine	Approved Investigational	PFKFB4	5210	upregulated	[Deferoxamine results in decreased abundance of Iron] which results in increased expression of PFKFB4 mRNA	3p21.31	A22072
Deferoxamine	Approved Investigational	PMP22	5376	downregulated	[Deferoxamine results in decreased abundance of Iron] which results in decreased expression of PMP22 mRNA	17p12	A22066
Deferoxamine	Approved Investigational	PTGS2	5743	upregulated	Deferoxamine results in increased expression of PTGS2 mRNA	1q31.1	A22073
Deferoxamine	Approved Investigational	RAMP2	10266	downregulated	Deferoxamine results in decreased expression of RAMP2 mRNA	17q12-q21.1	A22052
Deferoxamine	Approved Investigational	SETD1A	9739	upregulated	Deferoxamine results in increased expression of SETD1A mRNA	16p11.2	A22054
Deferoxamine	Approved Investigational	SETD2	29072	upregulated	Deferoxamine results in increased expression of SETD2 mRNA	3p21.31	A22054
Deferoxamine	Approved Investigational	SLC11A2	4891	upregulated	[Deferoxamine results in decreased abundance of Iron] which results in increased expression of SLC11A2 mRNA	12q13.12	A22066
Deferoxamine	Approved Investigational	SLC2A1	6513	upregulated	Deferoxamine results in increased expression of SLC2A1 mRNA	1p34.2	A22065 A22071
Deferoxamine	Approved Investigational	SLC2A4	6517	downregulated	Deferoxamine results in decreased expression of SLC2A4 mRNA	17p13.1	A22065
Deferoxamine	Approved Investigational	SUV39H1	6839	downregulated	Deferoxamine results in decreased expression of SUV39H1 mRNA	Xp11.23	A22054
Deferoxamine	Approved Investigational	SUV39H1	6839	upregulated	Deferoxamine results in increased expression of SUV39H1 mRNA	Xp11.23	A22054
Deferoxamine	Approved Investigational	TFRC	7037	upregulated	[Deferoxamine results in decreased abundance of Iron] which results in increased expression of TFRC mRNA	3q29	A22066
Deferoxamine	Approved Investigational	TFRC	7037	upregulated	Deferoxamine results in increased expression of TFRC mRNA	3q29	A22074 A22057
Deferoxamine	Approved Investigational	TNF	7124	downregulated	Deferoxamine results in decreased expression of TNF mRNA	6p21.33	A22069
Deferoxamine	Approved Investigational	TRAP1	10131	downregulated	Deferoxamine results in decreased expression of TRAP1 mRNA	16p13.3	A22075
Deferoxamine	Approved Investigational	UCP2	7351	downregulated	Deferoxamine results in decreased expression of UCP2 mRNA	11q13	A22065
Deferoxamine	Approved Investigational	VDR	7421	upregulated	Deferoxamine results in increased expression of VDR mRNA	12q13.11	A22076

Displaying entries 30026 - 30050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability